Prescription drug · ANDA
Desoximetasone NDC 71205-271
Desoximetasone 2.5 mg/g · Cream · Topical · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71205-271-15 | 71205027115 | 1 TUBE in 1 CARTON (71205-271-15) / 15 g in 1 TUBEMarketed from May 1, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Desoximetasone
- Generic name (nonproprietary)
- desoximetasone
- Active ingredients
- Desoximetasone — 2.5 mg/g
- Dosage form
- Cream
- Route
- Topical
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205082
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 71205-271_614ba5f2-9f66-40c7-b22c-1538492a7995SPL ID 614ba5f2-9f66-40c7-b22c-1538492a7995SPL set ID f30b6fcc-43bc-4d65-9c3b-8d6ca780a024RxCUI 197574UNII 4E07GXB7AUUPC 0371205271152
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471205027115followed by a unit qualifier and the quantityPackage 71205-0271-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Desoximetasone cream USP, 0.25% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Excerpt only. Read the full label for complete information.